We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
BUSINESS BRIEFS.
- Abstract
Reports on developments concerning pharmaceutical industry as of July 2005. Conditional approval received by Abbott Laboratories Inc. from the U.S. Food and Drug Administration to begin clinical trials for ZoMaxx drug-coated stent; Definitive agreement signed by Abiomed Inc., a manufacturer of products for circulatory care and support, to acquire Impella CardioSystems AG, a privately-held manufacturer of small, minimally invasive, high-performance micro blood pumps; Biophan Technologies Inc.'s completion of its acquisition of a majority interest in German firm Amris GmbH.
- Subjects
MATERIALS science; PHARMACEUTICAL industry; ABBOTT Laboratories Inc.; BIOPHAN Technologies Inc.; ABIOMED Inc.; IMPELLA CardioSystems AG; AMRIS GmbH
- Publication
Advanced Materials & Processes, 2005, Vol 163, Issue 7, p66
- ISSN
0882-7958
- Publication type
Article